Pages that link to "Q72617618"
Jump to navigation
Jump to search
The following pages link to Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension (Q72617618):
Displaying 32 items.
- Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: role of prostaglandin (Q33868828) (← links)
- Hepatorenal failure (Q34170377) (← links)
- Endothelial dysfunction in cirrhosis and portal hypertension (Q34342993) (← links)
- Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats (Q35026373) (← links)
- Eicosanoids in cirrhosis and portal hypertension (Q35588463) (← links)
- Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats (Q36410348) (← links)
- Impaired vasodilatory responses in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis (Q36698021) (← links)
- The Gastrointestinal Circulation: Physiology and Pathophysiology (Q38542463) (← links)
- Murine study of portal hypertension associated endothelin-1 hypo-response (Q39923460) (← links)
- Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension (Q40707200) (← links)
- Pharmacological treatment of portal hypertension: present and future (Q40855557) (← links)
- Recent advances in the pathophysiology of portal hypertension (Q41667308) (← links)
- Underlying Mechanisms of Portal Hypertensive Gastropathy (Q41710855) (← links)
- Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats (Q43048632) (← links)
- The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice. (Q44429830) (← links)
- Energy metabolism in portal hypertension in children (Q50998570) (← links)
- Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats (Q51502324) (← links)
- Effects of sustained-release lanreotide on hemodynamics in rats with portal vein stenosis. (Q54078891) (← links)
- Effects of l-arginine on the systemic, mesenteric, and Hepatic circulation in patients with cirrhosis (Q54147257) (← links)
- Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats (Q56925587) (← links)
- Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats (Q56925624) (← links)
- Enhanced nitric oxide synthase activity in portal hypertensive rabbits (Q71704795) (← links)
- Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats (Q71732679) (← links)
- Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats (Q71737301) (← links)
- Loss of angiotensin-II receptors in portal hypertensive rabbits (Q71958812) (← links)
- Increased prostacyclin content in gastric mucosa of cirrhotic patients with portal hypertensive gastropathy (Q72061379) (← links)
- Bilioenteric anastomosis reverses hyperkinetic circulation in bile duct-ligated cirrhotic rats (Q73011049) (← links)
- Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats (Q73167060) (← links)
- 1 Pathophysiology of portal hypertension (Q73935385) (← links)
- Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation (Q74027061) (← links)
- Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin (Q78171441) (← links)
- Pathophysiology of portal hypertension (Q81054593) (← links)